Sign up to save your podcasts
Or
Share Ep 9 - O que eu aprendi no 3 congresso da ASKP3
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep 9 - O que eu aprendi no 3 congresso da ASKP3
O Congresso americano de cetamina – askp3
Infusão de conhecimento
Este é um podcast para médicos sob responsabilidade do Dr. Tiago Gil, médico anestesista CRMSP 157384 RQE 64871
A medicina é uma ciência que está em evolução e este podcast não deve ser utilizado como guia terapêutico. Esse episódio foi gravado como verdade até novembro de 2020
Meu email é [email protected] e em varias redes sociais como “centro de cetamina”
Referencias bibliográficas
https://askp.org/2020-conference/
Friday, October 16th
8:00a – 8:30a PT/11:00a-11:30a ET State of the ASKP3 Union • Welcome, Recap of 2020 • Standards & Ethics Presentation 8:30a-10:00a PST/11:30a-1:00p EST
Lecture Block 1 • Jason Wallach, PhD– The Neuropharmacology of Ketamine •
Sagar Parikh, MD, FRCPC – Comparison of Different Duration Regimens for Intravenous Racemic Ketamine: 100-Minute Versus 40-Minute Infusions for Refractory Depression
Lecture Block 2 • Ravi Das. MD – Destabilization of maladaptive drinking memories combined with ketamine effectively reduced the reinforcing effects of alcohol and long-term drinking levels •
Sandhya Prashad, MD - The Use of Intranasal Esketamine Alongside Intravenous Ketamine in Clinical Practice
• Tiago Gil, MD - Ketamine is a common drug for depression and epilepsy, is there a shared pathophysiology? 1:00p-2:00p PST/4:00p-5:00p EST
2:00p-4:00p PST/5:00p-7:00p EST Lecture Block 3 • Will Van Derveer, MD – Suicidality and Inflammation: Improving and Extending Ketamine’s Efficacy • Megan Oxley, MD – A Safe Approach to at Home Ketamine Saturday, October 17th 8:00a-10:00a PST/11:00a-1:00p EST Lecture Block 1
James Murrough, MD, PhD - Discovering New Targets for the Treatment of Depression: Insights from Ketamine and Beyond •
Rupert McShane, MD – Understanding the Advantages and Disadvantages of Prescribing Ketamine Through Different Routes of Administration
11:00a-1:00p PST/2:00p-4:00p EST • Raquel Bennett, PsyD - Paradigms of Ketamine Treatment •
Gita Vaid, MD - TBD
1:00p-2:00p PST/4:00p-5:00p EST Conference Close • Meet your New Board Members • Closing Remarks •
2021 Conference Announcement
View all episodes
By Dr. Tiago GilO Congresso americano de cetamina – askp3
Infusão de conhecimento
Este é um podcast para médicos sob responsabilidade do Dr. Tiago Gil, médico anestesista CRMSP 157384 RQE 64871
A medicina é uma ciência que está em evolução e este podcast não deve ser utilizado como guia terapêutico. Esse episódio foi gravado como verdade até novembro de 2020
Meu email é [email protected] e em varias redes sociais como “centro de cetamina”
Referencias bibliográficas
https://askp.org/2020-conference/
Friday, October 16th
8:00a – 8:30a PT/11:00a-11:30a ET State of the ASKP3 Union • Welcome, Recap of 2020 • Standards & Ethics Presentation 8:30a-10:00a PST/11:30a-1:00p EST
Lecture Block 1 • Jason Wallach, PhD– The Neuropharmacology of Ketamine •
Sagar Parikh, MD, FRCPC – Comparison of Different Duration Regimens for Intravenous Racemic Ketamine: 100-Minute Versus 40-Minute Infusions for Refractory Depression
Lecture Block 2 • Ravi Das. MD – Destabilization of maladaptive drinking memories combined with ketamine effectively reduced the reinforcing effects of alcohol and long-term drinking levels •
Sandhya Prashad, MD - The Use of Intranasal Esketamine Alongside Intravenous Ketamine in Clinical Practice
• Tiago Gil, MD - Ketamine is a common drug for depression and epilepsy, is there a shared pathophysiology? 1:00p-2:00p PST/4:00p-5:00p EST
2:00p-4:00p PST/5:00p-7:00p EST Lecture Block 3 • Will Van Derveer, MD – Suicidality and Inflammation: Improving and Extending Ketamine’s Efficacy • Megan Oxley, MD – A Safe Approach to at Home Ketamine Saturday, October 17th 8:00a-10:00a PST/11:00a-1:00p EST Lecture Block 1
James Murrough, MD, PhD - Discovering New Targets for the Treatment of Depression: Insights from Ketamine and Beyond •
Rupert McShane, MD – Understanding the Advantages and Disadvantages of Prescribing Ketamine Through Different Routes of Administration
11:00a-1:00p PST/2:00p-4:00p EST • Raquel Bennett, PsyD - Paradigms of Ketamine Treatment •
Gita Vaid, MD - TBD
1:00p-2:00p PST/4:00p-5:00p EST Conference Close • Meet your New Board Members • Closing Remarks •
2021 Conference Announcement